Related Experiment Video
Updated: Apr 20, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Defining value-driven care in head and neck oncology
Benjamin R Roman1, Mahmoud I Awad, Snehal G Patel
1Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA, romanb@mskcc.org.
This study outlines a value-based healthcare framework for head and neck cancer care in the USA. It focuses on improving quality and outcomes while managing costs and treatment harms for better patient benefit.
Area of Science:
- Health Services Research
- Oncology
- Health Economics
Background:
- Healthcare systems are increasingly adopting value-based frameworks to improve care delivery.
- Value in healthcare is defined as the ratio of benefits (quality, outcomes) to costs (financial, harms).
Purpose of the Study:
- To describe the elements of value in head and neck cancer care.
- To identify physician-controlled aspects of the value equation.
- To establish a framework for value-based head and neck cancer care.
Main Methods:
- Examination of quality across structure, process, and outcomes.
- Application of Porter's three-tiered outcomes model to head and neck cancer.
- Review of cost and harm considerations in cancer treatment.
Main Results:
- Quality assessment includes structural, process, and outcome measures.
- Specific outcomes relevant to head and neck and thyroid cancer patients were identified.
- Cost and harm factors were analyzed within the value framework.
Conclusions:
- A structured approach to defining and measuring value is crucial for head and neck cancer care.
- Physician-centric strategies can enhance value by optimizing quality and managing costs.
- This framework supports efforts to improve value-based delivery in head and neck oncology.
More Related Videos
07:44Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Standards of Care I
Patient-centered Care